Insider Trading Alert - RAD, HERO And OIS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 25, 2014, 45 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $185.90 to $13,074,495.00.

Highlighted Stocks Traded by Insiders:

Rite Aid (RAD) - FREE Research Report

Anderson Joseph B Jr, who is Director at Rite Aid, sold 26,667 shares at $7.05 on June 25, 2014. Following this transaction, the Director owned 299,254 shares meaning that the stake was reduced by 8.18% with the 26,667-share transaction.

The shares most recently traded at $7.20, up $0.15, or 2.08% since the insider transaction. Historical insider transactions for Rite Aid go as follows:

  • 12-Week # shares bought: 40.0 million
  • 12-Week # shares sold: 34.0 million
  • 24-Week # shares bought: 40.0 million
  • 24-Week # shares sold: 34.0 million

The average volume for Rite Aid has been 30.2 million shares per day over the past 30 days. Rite Aid has a market cap of $6.9 billion and is part of the services sector and retail industry. Shares are up 42.49% year-to-date as of the close of trading on Wednesday.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company has a P/E ratio of 39.1. Currently, there are 3 analysts who rate Rite Aid a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RAD - FREE

TheStreet Quant Ratings rates Rite Aid as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and poor profit margins. Get the full Rite Aid Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval

Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree?